EBV reactivation mimicking a lymphoproliferative disorder associated with ruxolitinib therapy for myelofibrosis.

EBV reactivation mimicking a lymphoproliferative disorder associated with ruxolitinib therapy for myelofibrosis.
Blood Res. 2019 Dec;54(4):282-284
Authors: Prem S, Loach D, Lipton J, Kumar R, Gupta V
PMID: 31915655 [PubMed]

Source: Blood Research - January 10, 2020 Category: Hematology Tags: Blood Res Source Type: research